CID is 71412
synonyms found at PubChem are:
Labetalol hydrochloride, 32780-64-6, Labetalol HCL, Amipress, Presdate, Labrocol, Pressalolo, Ipolab, 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide hydrochloride, Labetalol (hydrochloride), UNII-1GEV3BAW9J, AH 5158A, ScH 15719W, CCRIS 1086, Labetalol hydrochloride, EINECS 251-211-1, 1GEV3BAW9J, NSC 290312, Sch-15719W, MLS000069666, AH-5158A, SMR000058463, Normodyne (TN), Trandate (TN), 5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide hydrochloride, 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide hydrochloride, 2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide hydrochloride, 5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride, DSSTox_CID_24654, DSSTox_RID_80378, Salicylamide, 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride, DSSTox_GSID_44654, C19H25ClN2O3, 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide monohydrochloride, Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, monohydrochloride, Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride(1:1), SR-01000000209, C19H24N2O3.HCl, 2-hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide hydrochloride, 2-Hydroxy-5-(1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl)benzamide hydrochloride, 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide hydrochloride, 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride, Prestwick_290, EINECS 276-694-6, Labetalol hydrochloride [USAN:JAN], Labetalol hydrochloride [USAN:USP:JAN], AC1Q5DEI, La.beta.lol hydrochloride, Opera_ID_1625, Benzamide,monohydrochloride, NCGC00016810-01, Salicylamide, hydrochloride, CAS-32780-64-6, SCHEMBL41230, MLS001148626, MLS002222197, SPECTRUM1503243, AC1L2G48, CHEBI:6344, CHEMBL1200323, DTXSID0044654, CTK4G9285, KS-00000GGU, AOB5072, MolPort-003-666-813, WQVZLXWQESQGIF-UHFFFAOYSA-N, HMS1568H16, HMS1922M13, Pharmakon1600-01503243, BCP13886, HY-B1108, Tox21_110623, Tox21_302725, Tox21_500687, CCG-40314, Labetalol hydrochloride (JP17/USP), MFCD00057663, NSC290312, NSC758438, s4291, AKOS015895575, AC-1389, API0003104, CS-4706, LP00687, NC00571, NSC-290312, NSC-758438, SS-4219, VA11135, NCGC00094044-01, NCGC00094044-02, NCGC00094044-03, NCGC00094044-04, NCGC00094044-05, NCGC00256847-01, NCGC00261372-01, (R*,R*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride, 72487-34-4, AK144692, AN-14950, BC678573, CPD000058463, Labetalol HCl (Mixture of Diastereomers), LS-26937, SAM002564217, SC-58270, 32780-64-6 (HCl), AX8135749, ST2410032, 4CH-016313, EU-0100687, FT-0630564, D00600, J10319, Labetalol hydrochloride, >98% (TLC), powder, 780L646, C-20992, I06-0868, SR-01000000209-2, SR-01000000209-7, 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide HCl, 2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl, Labetalol hydrochloride, European Pharmacopoeia (EP) Reference Standard, Labetalol hydrochloride, United States Pharmacopeia (USP) Reference Standard, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide hydrochloride, Labetalol Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-,monohydrochloride, Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride (1:1), AC1LCW63, AKOS026749871, hydron; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide; chloride